NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
34.83
-0.34 (-0.97%)
At close: Jul 2, 2026, 4:00 PM EDT
34.15
-0.68 (-1.95%)
After-hours: Jul 2, 2026, 7:10 PM EDT
NAMS Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $47 → $51 | Buy | Maintains | $47 → $51 | +46.43% | Jun 30, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $60 | Buy | Maintains | $60 | +72.27% | May 12, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 8, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $45 | Buy | Maintains | $45 | +29.20% | May 8, 2026 |
| Needham | Needham | Buy Maintains $48 | Buy | Maintains | $48 | +37.81% | May 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $48 → $52 | Buy | Reiterates | $48 → $52 | +49.30% | May 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.